Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.
about
Neglected parasitic infections and poverty in the United StatesNovel thioredoxin-like proteins are components of a protein complex coating the cortical microtubules of Toxoplasma gondiiLaboratory Diagnosis of Congenital ToxoplasmosisA meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection.IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in NewbornsCongenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-savingEvaluation of a new protocol for retrospective diagnosis of congenital toxoplasmosis by use of Guthrie cards.Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal-Maternal ToxoplasmosisToxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone.Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosisCerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.Congenital toxoplasmosis and prenatal care state programs.Adverse socioeconomic conditions and oocyst-related factors are associated with congenital toxoplasmosis in a population-based study in Minas Gerais, Brazil.Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversionsEvaluation of colostrum as an alternative biological sample for the diagnosis of human congenital toxoplasmosisA pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalusSignificance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis.Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective studyMultiplexed Anti-Toxoplasma IgG, IgM, and IgA Assay on Plasmonic Gold Chips: towards Making Mass Screening Possible with Dye Test Precision.Identification of functional modules of AKMT, a novel lysine methyltransferase regulating the motility of Toxoplasma gondii.Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment.Prenatal exposures associated with neurodevelopmental delay and disabilities.Toxoplasma gondii dissemination: a parasite's journey through the infected host.Role of vertical transmission of Toxoplasma gondii in prevalence of infection.Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.Seroprevalence of Toxoplasma gondii in Western Romania.Congenital toxoplasmosis: an uncommon disease in Thailand.Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.Reply to Wallon and Peyron.Evaluation of gene expression levels for cytokines in ocular toxoplasmosis.Human Placental Syncytiotrophoblasts Restrict Toxoplasma gondii Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines.Two key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis.Evaluation of Three Point-of-Care Tests for Detection of Immunoglobulin IgG and IgM in the United States: Proof of Concept and ChallengesGlobal initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis
P2860
Q21092273-18A2E524-0C35-472E-9F0D-BFA580ADFF45Q27973671-50B9A7B0-C7AA-4603-B12B-DD00BBE08046Q28067188-869A976D-1EE7-4F8B-836D-9901CEE1F341Q33618593-B70A5A66-98E3-4B15-9E3A-9CF165C2A614Q33847295-054B9425-09C8-412A-ACA5-577314AB7501Q33887872-1C5A0AC3-CEE6-43C9-88F1-FEEB70E8A538Q34058846-97160A25-93B4-408A-96F6-E446986CA307Q34149967-17772DC6-4A13-483D-BE0D-CFD8E6A6F635Q34180868-9F58474B-C950-4E65-923B-C1CC120F8916Q34307139-D2FA8697-2B0D-4C49-9423-1CA658F53057Q34330571-79A76150-6F53-4088-ABB2-A6A9F29429FCQ34504353-86811CFE-FB30-4CD1-BAC1-D433F421FAA4Q35085686-C43C34D6-5316-43DA-AD88-73959D18F4A2Q35093691-673B2659-3C43-43D0-8882-68FEA762C120Q35221173-9D4DBE83-D556-4E05-A024-823E7A80C689Q35842858-CBED1BF3-66D3-411C-9283-7FB9D3E290EBQ35921984-B55DA796-6AD2-45EB-B778-640205426602Q36173989-F9BD6F20-8131-46A1-A88F-5CEC475153A3Q36311448-A8E83A7C-A58F-4313-ACBD-33E3580F4B51Q36378655-71DB5D2D-28DD-4CE5-AFB7-E80784106D56Q36471061-FAB0B7AA-A2EF-4CA2-8FAF-E2801451722AQ36971075-6F4CBF11-18C4-42C7-8795-3EA0FE08538CQ37040542-8E83EB27-41B8-4F0D-94EA-A70E5BA63A4AQ37086743-FF9923AE-278A-4408-B299-8A16254FF92AQ37635732-95BE4863-116C-4C28-9605-6D9E3329B81FQ38024897-946F1BAA-B558-41CB-83D4-A291F2C5488BQ38040154-B4F8E39C-22AD-47CF-A057-BFDD9D1F60B0Q38077730-8DB1DD88-D890-4466-BC16-C03E517A2FF5Q38269429-6D272103-3FB2-4A1A-8541-646F9FE3DEE4Q38710473-477ABC54-2A8A-4CA7-8EB4-B3E7E19FF9EBQ39812716-C27392F8-891F-4EC6-85F3-800E485CAEC7Q40270407-79D66BCE-CD0C-4FFD-89FE-E4194915F333Q41577523-A67D60B1-542F-44A8-92F9-E561478C8D68Q42277120-9E2382EA-686F-4108-80CB-5D3C35ADBC46Q42612923-1A74DE08-4F8C-467B-B5D1-8F209C91CA4CQ47912179-B50FFD95-4463-4508-BF6B-91F3101D8C6AQ48277104-ADE15FDA-AAC1-402C-8CAC-A25C94354394Q52642725-C92E6299-BEE4-4199-93D5-B225448FB1D5Q58599099-D5269CB0-4796-42EB-AAC9-9E1F7141F861Q59129124-CFD6EE17-B0C8-46B2-B5F4-05914D801CB5
P2860
Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Severe congenital toxoplasmosi ...... findings in untreated infants.
@en
Severe congenital toxoplasmosi ...... findings in untreated infants.
@nl
type
label
Severe congenital toxoplasmosi ...... findings in untreated infants.
@en
Severe congenital toxoplasmosi ...... findings in untreated infants.
@nl
prefLabel
Severe congenital toxoplasmosi ...... findings in untreated infants.
@en
Severe congenital toxoplasmosi ...... findings in untreated infants.
@nl
P2093
P1476
Severe congenital toxoplasmosi ...... findings in untreated infants.
@en
P2093
Ambereen Alam
Jack S Remington
Jose G Montoya
Rima McLeod
Tudor Rares Olariu
P304
P356
10.1097/INF.0B013E3182343096
P577
2011-12-01T00:00:00Z